Gelatin intake increases the atheroma formation in apoE knock out mice.
The effect of gelatin ingestion on cholesterol metabolism and on atheroma formation was evaluated in both wild type (n=14) and apoprotein E (apoE) knock out (apoE(-/-)) (n=20) C57BL/6 7-week-old mice. Animals were fed a cholesterol-free isoproteic semi-purified diet containing 20% of casein (control diet) or 10% of casein plus 10% of gelatin (gel diet) for 8 weeks. In wild type mice, dietary gelatin caused a reduction in the serum triacylglycerols levels associated with an increase in the fecal excretion. No difference in blood cholesterol was seen at the sixth week of experiment. At the eighth week of experiment, there was a modest but significant reduction of serum total and high density lipoprotein (HDL) cholesterol in apoE(-/-) mice fed on gel diet compared to the control. Total cholesterol/HDL cholesterol ratio was 2-fold higher in the gel group than that seen in the control group (14.39 and 7.84, respectively). Histological analyzes showed a 2.2-fold increase in the dimension of the atherosclerotic plaques in the proximal aorta in apoE(-/-) mice fed on a gel diet compared to those fed on a control diet. The gel diet also promoted a reduction in the fecal excretion of bile acids. Hepatic cholesterol was similar in both groups. In conclusion, although gelatin reduced total serum cholesterol, this reduction was associated to a decrease of HDL cholesterol and consequent increase of total cholesterol/HDL cholesterol ratio, resulting in an acceleration of atherogenesis.
Oliveira
D R
DR
Departamento de Bioquímica e Imunologia, Laboratório de Gnotobiologia e Nutrição, Instituto de Ciências Biológicas (ICB), Universidade Federal de Minas Gerais (UFMG), Caixa Postal 486, 30. 161-970, MG, Belo Horizonte, Brazil.
Portugal
L R
LR
Cara
D C
DC
Vieira
E C
EC
Alvarez-Leite
J I
JI
D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000473:pathology; D001057:Apolipoproteins E / Q000172:deficiency* / Q000235:genetics; D001161:Arteriosclerosis / Q000209:etiology* / Q000473:pathology; D002364:Caseins / Q000008:administration & dosage / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000037:antagonists & inhibitors / Q000097:blood; D004032:Diet; D005260:Female; D005780:Gelatin / Q000008:administration & dosage*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout / Q000235:genetics; D010600:Pharmacology
D001057:Apolipoproteins E; D002364:Caseins; D008076:Cholesterol, HDL; D005780:Gelatin; D002784:Cholesterol